S100A7 and breast cancer: In vitro, treatment of LPS on an S100A7 overexcited in breast cancer cell line (MDA-MB-231), and in vivo treatment of MVT-1 (mouse mammary tumor cell line) with mS100A7/A15 revealed enhanced RAGE manifestation in a dose-dependent and time-dependent manner [75,300].